PURPLE BIOTECH LTD.

Profile

Company Names

PURPLE BIOTECH LTD.
KITOV PHARMA LTD.
KITOV PHARMACEUTICALS HOLDINGS LTD.

Addresses

4 OPPENHEIMER STREET, SCIENCE PARK, REHOVOT, L3 7670104

ONE AZRIELI CENTER, ROUND TOWER, 132 MENACHEM BEGIN ROAD, TEL AVIV, L3 6701101

ONE AZRIELI CENTER, ROUND TOWER, TEL AVIV, L3 6701101

ONE AZRIELI CENTER, ROUND BUILDING, 19TH FLOOR, TEL AVIV, L3 6701101

ONE AZRIELI CENTER, ROUND TOWER, FLOOR 19, TEL AVIV, L3 6701101

ONE AZRIELI CENTER, ROUND BUILDING, TEL AVIV, L3 6701101

ONE AZRIELI CENTER,, ROUND BUILDING, 23RD FLOOR, TEL AVIV, L3 6701101

Phone Numbers

+972-3-933-3121
97239333121
972-3-9333121
011972525328200

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY, PHARMACEUTICALS

Year Incorporated:

> 5 years ago

State Incorporated:

ISRAEL

Total Amount Raised:

$42,572,598.00

Number of Funding Rounds:

13
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
13
2024-07-01 
$4,506,807.00 
$4,506,807.00 
$0.00 
 
12
2023-10-17 
$5,434,784.00 
$5,434,784.00 
$0.00 
 
11
2020-05-24 
$0.00 
INDEFINITE 
INDEFINITE 
Equity 
10
2020-05-06 
$10,000,001.00 
$10,000,001.00 
$0.00 
 
9
2020-04-19 
$6,500,000.00 
$6,500,000.00 
$0.00 
 
8
2020-01-07 
$0.00 
$0.00 
$0.00 
Equity 
7
2019-01-18 
$6,000,001.00 
$6,000,001.00 
$0.00 
 
6
2018-06-05 
$8,150,000.00 
$8,150,000.00 
$0.00 
 
5
2018-03-15 
$0.00 
$0.00 
$0.00 
Equity 
4
2017-10-30 
$0.00 
INDEFINITE 
INDEFINITE 
Equity 
3
2017-07-11 
$1,981,005.00 
$1,981,005.00 
$0.00 
 
2
2016-05-02 
$0.00 
INDEFINITE 
INDEFINITE 
Equity 
1
2016-01-20 
$0.00 
INDEFINITE 
INDEFINITE 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
GIL 
 
BEN-MENACHEM 
EXECUTIVE OFFICER, DIRECTOR
AVRAHAM 
 
BEN-TZVI 
EXECUTIVE OFFICER
GIL 
 
EFRON 
EXECUTIVE OFFICER
LIOR 
 
FHIMA 
EXECUTIVE OFFICER
ROBERT 
 
GAGNON 
DIRECTOR
ORI 
 
HERSHKOVITZ 
DIRECTOR
ISAAC 
 
ISRAEL 
DIRECTOR, EXECUTIVE OFFICER
YAIR 
 
KATZIR 
DIRECTOR
BERTRAND 
 
LIANG 
EXECUTIVE OFFICER
YAEL 
 
MARGOLIN 
DIRECTOR
IDO 
 
MORPURGO 
EXECUTIVE OFFICER
SUZANA 
 
NAHUM-ZILBERBERG 
DIRECTOR
HADAS 
 
REUVENI 
EXECUTIVE OFFICER
SIMCHA 
 
ROCK 
DIRECTOR, EXECUTIVE OFFICER
ERIC 
 
ROWINSKY 
DIRECTOR
MICHAEL 
 
SCHICKLER 
EXECUTIVE OFFICER
FABIEN 
 
SEBILLE 
EXECUTIVE OFFICER
PHILIP 
 
SERLIN 
DIRECTOR
MORAN 
 
SHERF-BLAU 
DIRECTOR
REVITAL 
 
STERN-RAFF 
DIRECTOR
RAN 
 
TZROR 
DIRECTOR
JOHN PAUL 
 
WAYMACK 
EXECUTIVE OFFICER, DIRECTOR
ARYE 
 
WEBER 
DIRECTOR
ALAIN 
 
ZEITOUN 
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2024-07-01 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
NO REVENUES 
 
2023-10-17 
D
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2020-05-24 
D
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2020-05-06 
D
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2020-04-19 
D
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2020-01-07 
D
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2019-01-18 
D
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2018-06-05 
D
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2018-03-15 
D
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2017-10-30 
D
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2017-07-11 
D
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2016-05-02 
D
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2016-01-20 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
H.C. WAINWRIGHT + CO., LLC
NONE
NONE
H.C. WAINWRIGHT + CO., LLC
375
NONE
NONE
NONE
NONE
NONE
NONE
H.C. WAINWRIGHT + CO., LLC
375
NONE
NONE
RODMAN + RENSHAW, A UNIT OF H.C. WAINWRIGHT + CO., LLC
375